Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors

Cancer Genetics and Cytogenetics

Volumn 172, Issue 1, 2007, Pages 61-65

  Schaub, Rahel ^a   Burger, Alexa ^a   Bausch, Damaris ^a   Niggli, Felix K ^a   Schäfer, Beat W ^a   Betts, David R ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CASE REPORT; CHILDHOOD CANCER; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BAND; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; MALE; NEPHROBLASTOMA; ONCOGENE C MYB; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; STAINING;

CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 2; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; KIDNEY NEOPLASMS; MALE; NUCLEAR PROTEINS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; WILMS TUMOR;

EID: 33845454100     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.08.010     Document Type: Article

References (25)

1. Coppes M.J., Bonetta L., Huang A., Hoban P., Chilton-MacNeill S., Campbell C.E., Weksberg R., Yeger H., Reeve A.E., and Williams B.R. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination. Genes Chromosomes Cancer 5 (1992) 326-334 (Review)
2. Huff V. Wilms tumor genetics. Am J Med Genet 79 (1998) 260-267 (Review)
3. Lee S.B., and Haber D.A. Wilms tumor and the WT1 gene. Exp Cell Res 264 (2001) 74-99 (Review)
4. Koesters R., Niggli F., von Knebel Doeberitz M., and Stallmach T. Nuclear accumulation of beta-catenin protein in Wilms' tumours. J Pathol 199 (2003) 68-76
5. Bardeesy N., Falkoff D., Petruzzi M.J., Nowak N., Zabel B., Adam M., Aguiar M.C., Grundy P., Shows T., and Pelletier J. Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 7 (1994) 91-97
6. Betts D.R., Koesters R., Pluss H.J., and Niggli F.K. Trisomy 1q generating translocations in Wilms tumor. Cancer Genet Cytogenet 112 (1999) 138-143
7. Gow K.W., and Murphy J.J. Cytogenetic and histologic findings in Wilms' tumor. J Pediatr Surg 37 (2002) 823-827
8. Kullendorff C.M., Soller M., Wiebe T., and Mertens F. Cytogenetic findings and clinical course in a consecutive series of Wilms tumors. Cancer Genet Cytogenet 140 (2003) 82-87
9. Hoglund M., Gisselsson D., Hansen G.B., and Mitelman F. Wilms tumors develop through two distinct karyotypic pathways. Cancer Genet Cytogenet 150 (2004) 9-15
10. Peres E.M., Savasan S., Cushing B., Abella S., and Mohamed A.N. Chromosome analyses of 16 cases of Wilms tumor: different pattern in unfavorable histology. Cancer Genet Cytogenet 148 (2004) 66-70
11. Yuan E., Li C.M., Yamashiro D.J., Kandel J., Thaker H., Murty V.V., and Tycko B. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors. Mol Cancer Res 3 (2005) 493-502
12. Getman M.E., Houseal T.W., Miller G.A., Grundy P.E., Cowell J.K., and Landes G.M. Comparative genomic hybridization and its application to Wilms' tumorigenesis. Cytogenet Cell Genet 82 (1998) 284-290
13. Hing S., Lu Y.J., Summersgill B., King-Underwood L., Nicholson J., Grundy P., Grundy R., Gessler M., Shipley J., and Pritchard-Jones K. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol 158 (2001) 393-398
14. Grundy P.E., Breslow N.E., Li S., Perlman E., Beckwith J.B., Ritchey M.L., Shamberger R.C., Haase G.M., D'Angio G.J., Donaldson M., Coppes M.J., Malogolowkin M., Shearer P., Thomas P.R., Macklis R., Tomlinson G., Huff V., Green D.M., and National Wilms Tumor Study Group. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23 (2005) 7312-7321
15. Pinkel D., and Albertson D.G. Comparative genomic hybridization. Annu Rev Genomics Hum Genet 6 (2005) 331-354 (Review)
16. Albertson D.G., and Pinkel D. Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 12 (2003) 145-152
17. Schwaenen C., Wessendorf S., Kestler H.A., Dohner H., Lichter P., and Bentz M. DNA microarray analysis in malignant lymphomas. Ann Hematol 82 (2003) 323-332
18. Scaruffi P., Valent A., Schramm A., Astrahantseff K., Eggert A., and Tonini G.P. Application of microarray-based technology to neuroblastoma. Cancer Lett 228 (2005) 13-20
19. Betts D.R., Koesters R., Pluss H.J., and Niggli F.K. Routine karyotyping in Wilms tumor. Cancer Genet Cytogenet 96 (1997) 151-156
20. Mitelmann F. ISCN. An international system for cytogenetic nomenclature (1995), S Karger, Basel
21. Steenman M., Redeker B., de Meulemeester M., Wiesmeijer K., Voute P.A., Westerveld A., Slater R., and Mannens M. Comparative genomic hybridization analysis of Wilms tumors. Cytogenet Cell Genet 77 (1997) 296-303
22. Goldstein M., Rennert H., Bar-Shira A., Burstein Y., Yaron Y., and Orr-Urtreger A. Combined cytogenetic and array-based comparative genomic hybridization analyses of Wilms tumors: amplification and overexpression of the multidrug resistance associated protein 1 gene (MRP1) in a metachronous tumor. Cancer Genet Cytogenet 141 (2003) 120-127
23. Schlomm T., Gunawan B., Schulten H.J., Sander B., Thangavelu K., Graf N., Leuschner I., Ringert R.H., and Fuzesi L. Effects of chemotherapy on the cytogenetic constitution of Wilms' tumor. Clin Cancer Res 11 (2005) 4382-4387
24. Corvi R., Savelyeva L., and Schwab M. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Cancer Res 55 (1995) 3471-3474
25. Zirn B., Hartmann O., Samans B., Krause M., Wittmann S., Mertens F., Graf N., Eilers M., and Gessler M. Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters. Int J Cancer 118 (2006) 1954-1962